RECKing MMP function: Implications for cancer development

Jin Sae Rhee, Lisa Coussens

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Cancer is a multistage process requiring progressive genetic and epigenetic changes in neoplastic and responding stromal cells. Many alterations that occur during the process of malignant progression are regulated by the matrix metalloproteinase (MMP) family of extracellular proteases and their endogenous inhibitors. Recent work has identified a new cell-surface inhibitor of MMPs - RECK. RECK regulates MMP-induced pericellular signaling cascades during embryogenesis and tumorigenesis. Homozygous loss of RECK results in embryonic lethality and attenuated tumor development in adults - thus providing further support for an efficacious role for protease inhibitors as anticancer therapeutics.

Original languageEnglish (US)
Pages (from-to)209-211
Number of pages3
JournalTrends in Cell Biology
Volume12
Issue number5
DOIs
StatePublished - May 1 2002
Externally publishedYes

Fingerprint

Matrix Metalloproteinases
Matrix Metalloproteinase Inhibitors
Stromal Cells
Protease Inhibitors
Epigenomics
Embryonic Development
Neoplasms
Carcinogenesis
Peptide Hydrolases
Therapeutics

ASJC Scopus subject areas

  • Cell Biology

Cite this

RECKing MMP function : Implications for cancer development. / Rhee, Jin Sae; Coussens, Lisa.

In: Trends in Cell Biology, Vol. 12, No. 5, 01.05.2002, p. 209-211.

Research output: Contribution to journalArticle

@article{03ab20a988f14d00a95c860ed538b57d,
title = "RECKing MMP function: Implications for cancer development",
abstract = "Cancer is a multistage process requiring progressive genetic and epigenetic changes in neoplastic and responding stromal cells. Many alterations that occur during the process of malignant progression are regulated by the matrix metalloproteinase (MMP) family of extracellular proteases and their endogenous inhibitors. Recent work has identified a new cell-surface inhibitor of MMPs - RECK. RECK regulates MMP-induced pericellular signaling cascades during embryogenesis and tumorigenesis. Homozygous loss of RECK results in embryonic lethality and attenuated tumor development in adults - thus providing further support for an efficacious role for protease inhibitors as anticancer therapeutics.",
author = "Rhee, {Jin Sae} and Lisa Coussens",
year = "2002",
month = "5",
day = "1",
doi = "10.1016/S0962-8924(02)02280-8",
language = "English (US)",
volume = "12",
pages = "209--211",
journal = "Trends in Cell Biology",
issn = "0962-8924",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - RECKing MMP function

T2 - Implications for cancer development

AU - Rhee, Jin Sae

AU - Coussens, Lisa

PY - 2002/5/1

Y1 - 2002/5/1

N2 - Cancer is a multistage process requiring progressive genetic and epigenetic changes in neoplastic and responding stromal cells. Many alterations that occur during the process of malignant progression are regulated by the matrix metalloproteinase (MMP) family of extracellular proteases and their endogenous inhibitors. Recent work has identified a new cell-surface inhibitor of MMPs - RECK. RECK regulates MMP-induced pericellular signaling cascades during embryogenesis and tumorigenesis. Homozygous loss of RECK results in embryonic lethality and attenuated tumor development in adults - thus providing further support for an efficacious role for protease inhibitors as anticancer therapeutics.

AB - Cancer is a multistage process requiring progressive genetic and epigenetic changes in neoplastic and responding stromal cells. Many alterations that occur during the process of malignant progression are regulated by the matrix metalloproteinase (MMP) family of extracellular proteases and their endogenous inhibitors. Recent work has identified a new cell-surface inhibitor of MMPs - RECK. RECK regulates MMP-induced pericellular signaling cascades during embryogenesis and tumorigenesis. Homozygous loss of RECK results in embryonic lethality and attenuated tumor development in adults - thus providing further support for an efficacious role for protease inhibitors as anticancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=0036569084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036569084&partnerID=8YFLogxK

U2 - 10.1016/S0962-8924(02)02280-8

DO - 10.1016/S0962-8924(02)02280-8

M3 - Article

C2 - 12062160

AN - SCOPUS:0036569084

VL - 12

SP - 209

EP - 211

JO - Trends in Cell Biology

JF - Trends in Cell Biology

SN - 0962-8924

IS - 5

ER -